Royal Bank Of Canada Aspira Women'S Health Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.32 - $0.58 $9 - $17	30 Added 4.93%	639 $0
Q4 2022 Feb 14, 2023	BUY	$0.3 - $0.41 $66 - $90	221 Added 56.96%	609 $0
Q3 2022 Nov 14, 2022	BUY	$0.38 - $1.07 $83 - $235	220 Added 130.95%	388 $0
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $1,719 - $4,685	-4,299 Reduced 96.24%	168 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $11,064 - $22,757	-12,573 Reduced 73.79%	4,467 $5,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $13,175 - $27,724	8,083 Added 90.24%	17,040 $30,000
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $1,244 - $2,137	-390 Reduced 4.17%	8,957 $29,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $44,678 - $63,933	9,347 New	9,347 $53,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.